{"@context":{"@vocab":"https://cir.nii.ac.jp/schema/1.0/","rdfs":"http://www.w3.org/2000/01/rdf-schema#","dc":"http://purl.org/dc/elements/1.1/","dcterms":"http://purl.org/dc/terms/","foaf":"http://xmlns.com/foaf/0.1/","prism":"http://prismstandard.org/namespaces/basic/2.0/","cinii":"http://ci.nii.ac.jp/ns/1.0/","datacite":"https://schema.datacite.org/meta/kernel-4/","ndl":"http://ndl.go.jp/dcndl/terms/","jpcoar":"https://github.com/JPCOAR/schema/blob/master/2.0/"},"@id":"https://cir.nii.ac.jp/crid/1363670320749759744.json","@type":"Article","productIdentifier":[{"identifier":{"@type":"DOI","@value":"10.1002/hep.22549"}},{"identifier":{"@type":"URI","@value":"https://api.wiley.com/onlinelibrary/tdm/v1/articles/10.1002%2Fhep.22549"}},{"identifier":{"@type":"URI","@value":"https://journals.lww.com/01515467-200812000-00007"}}],"dc:title":[{"@value":"Naturally occurring dominant resistance mutations to hepatitis C virus protease and polymerase inhibitors in treatment-naïve patients"}],"description":[{"type":"abstract","notation":[{"@value":"<jats:sec>\n            <jats:title>Abstract</jats:title>\n            <jats:p>\n                                 <jats:bold>Resistance mutations to hepatitis C virus (HCV) nonstructural protein 3 (NS3) protease inhibitors in <1% of the viral quasispecies may still allow >1000-fold viral load reductions upon treatment, consistent with their reported reduced replicative fitness</jats:bold>\n                                 <jats:bold>\n                                    in vitro\n                                 </jats:bold>\n                                 <jats:bold>. Recently, however, an R155K protease mutation was reported as the dominant quasispecies in a treatment-naïve individual, raising concerns about possible full drug resistance. To investigate the prevalence of dominant resistance mutations against specifically targeted antiviral therapy for HCV (STAT-C) in the population, we analyzed HCV genome sequences from 507 treatment-naïve patients infected with HCV genotype 1 from the United States, Germany, and Switzerland. Phylogenetic sequence analysis and viral load data were used to identify the possible spread of replication-competent, drug-resistant viral strains in the population and to infer the consequences of these mutations upon viral replication</jats:bold>\n                                 <jats:bold>\n                                    in vivo\n                                 </jats:bold>\n                                 <jats:bold>. Mutations described to confer resistance to the protease inhibitors Telaprevir, BILN2061, ITMN-191, SCH6 and Boceprevir; the NS5B polymerase inhibitor AG-021541; and to the NS4A antagonist ACH-806 were observed mostly as sporadic, unrelated cases, at frequencies between 0.3% and 2.8% in the population, including two patients with possible multidrug resistance. Collectively, however, 8.6% of the patients infected with genotype 1a and 1.4% of those infected with genotype 1b carried at least one dominant resistance mutation. Viral loads were high in the majority of these patients, suggesting that drug-resistant viral strains might achieve replication levels comparable to nonresistant viruses</jats:bold>\n                                 <jats:bold>\n                                    in vivo\n                                 </jats:bold>\n                                 <jats:bold>.</jats:bold>\n                                 <jats:bold>\n                                    Conclusion:\n                                 </jats:bold>\n                                 <jats:bold>Naturally occurring dominant STAT-C resistance mutations are common in treatment-naïve patients infected with HCV genotype 1. Their influence on treatment outcome should further be characterized to evaluate possible benefits of drug resistance testing for individual tailoring of drug combinations when treatment options are limited due to previous nonresponse to peginterferon and ribavirin. (Hepatology 2008;48:1769–1778.)</jats:bold>\n                              </jats:p>\n          </jats:sec>"}]}],"creator":[{"@id":"https://cir.nii.ac.jp/crid/1383670320749759625","@type":"Researcher","foaf:name":[{"@value":"Thomas Kuntzen"}]},{"@id":"https://cir.nii.ac.jp/crid/1383670320749759633","@type":"Researcher","foaf:name":[{"@value":"Joerg Timm"}]},{"@id":"https://cir.nii.ac.jp/crid/1383670320749759624","@type":"Researcher","foaf:name":[{"@value":"Andrew Berical"}]},{"@id":"https://cir.nii.ac.jp/crid/1383670320749759627","@type":"Researcher","foaf:name":[{"@value":"Niall Lennon"}]},{"@id":"https://cir.nii.ac.jp/crid/1383670320749759626","@type":"Researcher","foaf:name":[{"@value":"Aaron M. Berlin"}]},{"@id":"https://cir.nii.ac.jp/crid/1383670320749759744","@type":"Researcher","foaf:name":[{"@value":"Sarah K. Young"}]},{"@id":"https://cir.nii.ac.jp/crid/1383670320749759490","@type":"Researcher","foaf:name":[{"@value":"Bongshin Lee"}]},{"@id":"https://cir.nii.ac.jp/crid/1383670320749759757","@type":"Researcher","foaf:name":[{"@value":"David Heckerman"}]},{"@id":"https://cir.nii.ac.jp/crid/1383670320749759622","@type":"Researcher","foaf:name":[{"@value":"Jonathan Carlson"}]},{"@id":"https://cir.nii.ac.jp/crid/1383670320749759493","@type":"Researcher","foaf:name":[{"@value":"Laura L. Reyor"}]},{"@id":"https://cir.nii.ac.jp/crid/1383670320749759751","@type":"Researcher","foaf:name":[{"@value":"Marianna Kleyman"}]},{"@id":"https://cir.nii.ac.jp/crid/1383670320749759616","@type":"Researcher","foaf:name":[{"@value":"Cory M. McMahon"}]},{"@id":"https://cir.nii.ac.jp/crid/1383670320749759496","@type":"Researcher","foaf:name":[{"@value":"Christopher Birch"}]},{"@id":"https://cir.nii.ac.jp/crid/1383670320749759489","@type":"Researcher","foaf:name":[{"@value":"Julian Schulze zur Wiesch"}]},{"@id":"https://cir.nii.ac.jp/crid/1383670320749759629","@type":"Researcher","foaf:name":[{"@value":"Timothy Ledlie"}]},{"@id":"https://cir.nii.ac.jp/crid/1383670320749759746","@type":"Researcher","foaf:name":[{"@value":"Michael Koehrsen"}]},{"@id":"https://cir.nii.ac.jp/crid/1383670320749759756","@type":"Researcher","foaf:name":[{"@value":"Chinnappa Kodira"}]},{"@id":"https://cir.nii.ac.jp/crid/1383670320749759494","@type":"Researcher","foaf:name":[{"@value":"Andrew D. Roberts"}]},{"@id":"https://cir.nii.ac.jp/crid/1383670320749759621","@type":"Researcher","foaf:name":[{"@value":"Georg M. Lauer"}]},{"@id":"https://cir.nii.ac.jp/crid/1383670320749759620","@type":"Researcher","foaf:name":[{"@value":"Hugo R. Rosen"}]},{"@id":"https://cir.nii.ac.jp/crid/1383670320749759747","@type":"Researcher","foaf:name":[{"@value":"Florian Bihl"}]},{"@id":"https://cir.nii.ac.jp/crid/1383670320749759499","@type":"Researcher","foaf:name":[{"@value":"Andreas Cerny"}]},{"@id":"https://cir.nii.ac.jp/crid/1383670320749759749","@type":"Researcher","foaf:name":[{"@value":"Ulrich Spengler"}]},{"@id":"https://cir.nii.ac.jp/crid/1383670320749759500","@type":"Researcher","foaf:name":[{"@value":"Zhimin Liu"}]},{"@id":"https://cir.nii.ac.jp/crid/1383670320749759748","@type":"Researcher","foaf:name":[{"@value":"Arthur Y. Kim"}]},{"@id":"https://cir.nii.ac.jp/crid/1383670320749759488","@type":"Researcher","foaf:name":[{"@value":"Yanming Xing"}]},{"@id":"https://cir.nii.ac.jp/crid/1383670320749759630","@type":"Researcher","foaf:name":[{"@value":"Arne Schneidewind"}]},{"@id":"https://cir.nii.ac.jp/crid/1383670320749759495","@type":"Researcher","foaf:name":[{"@value":"Margaret A. Madey"}]},{"@id":"https://cir.nii.ac.jp/crid/1383670320749759755","@type":"Researcher","foaf:name":[{"@value":"Jaquelyn F. Fleckenstein"}]},{"@id":"https://cir.nii.ac.jp/crid/1383670320749759745","@type":"Researcher","foaf:name":[{"@value":"Vicki M. Park"}]},{"@id":"https://cir.nii.ac.jp/crid/1383670320749759619","@type":"Researcher","foaf:name":[{"@value":"James E. Galagan"}]},{"@id":"https://cir.nii.ac.jp/crid/1383670320749759497","@type":"Researcher","foaf:name":[{"@value":"Chad Nusbaum"}]},{"@id":"https://cir.nii.ac.jp/crid/1383670320749759491","@type":"Researcher","foaf:name":[{"@value":"Bruce D. Walker"}]},{"@id":"https://cir.nii.ac.jp/crid/1383670320749759753","@type":"Researcher","foaf:name":[{"@value":"Gerond V. Lake-Bakaar"}]},{"@id":"https://cir.nii.ac.jp/crid/1383670320749759632","@type":"Researcher","foaf:name":[{"@value":"Eric S. Daar"}]},{"@id":"https://cir.nii.ac.jp/crid/1383670320749759628","@type":"Researcher","foaf:name":[{"@value":"Ira M. Jacobson"}]},{"@id":"https://cir.nii.ac.jp/crid/1383670320749759631","@type":"Researcher","foaf:name":[{"@value":"Edward D. Gomperts"}]},{"@id":"https://cir.nii.ac.jp/crid/1383670320749759617","@type":"Researcher","foaf:name":[{"@value":"Brian R. Edlin"}]},{"@id":"https://cir.nii.ac.jp/crid/1383670320749759492","@type":"Researcher","foaf:name":[{"@value":"Sharyne M. Donfield"}]},{"@id":"https://cir.nii.ac.jp/crid/1383670320749759623","@type":"Researcher","foaf:name":[{"@value":"Raymond T. Chung"}]},{"@id":"https://cir.nii.ac.jp/crid/1383670320749759618","@type":"Researcher","foaf:name":[{"@value":"Andrew H. Talal"}]},{"@id":"https://cir.nii.ac.jp/crid/1383670320749759750","@type":"Researcher","foaf:name":[{"@value":"Tony Marion"}]},{"@id":"https://cir.nii.ac.jp/crid/1383670320749759498","@type":"Researcher","foaf:name":[{"@value":"Bruce W. Birren"}]},{"@id":"https://cir.nii.ac.jp/crid/1383670320749759754","@type":"Researcher","foaf:name":[{"@value":"Matthew R. Henn"}]},{"@id":"https://cir.nii.ac.jp/crid/1383670320749759752","@type":"Researcher","foaf:name":[{"@value":"Todd M. Allen"}]}],"publication":{"publicationIdentifier":[{"@type":"PISSN","@value":"02709139"}],"prism:publicationName":[{"@value":"Hepatology"}],"dc:publisher":[{"@value":"Ovid Technologies (Wolters Kluwer Health)"}],"prism:publicationDate":"2008-12","prism:volume":"48","prism:number":"6","prism:startingPage":"1769","prism:endingPage":"1778"},"reviewed":"false","dc:rights":["http://doi.wiley.com/10.1002/tdm_license_1.1"],"url":[{"@id":"https://api.wiley.com/onlinelibrary/tdm/v1/articles/10.1002%2Fhep.22549"},{"@id":"https://journals.lww.com/01515467-200812000-00007"}],"createdAt":"2008-07-28","modifiedAt":"2024-12-01","relatedProduct":[{"@id":"https://cir.nii.ac.jp/crid/1050001335723502720","@type":"Article","resourceType":"学術雑誌論文(journal article)","relationType":["isReferencedBy"],"jpcoar:relatedTitle":[{"@language":"en","@value":"Genetic heterogeneity of hepatitis C virus in association with antiviral therapy determined by ultra-deep sequencing."}]},{"@id":"https://cir.nii.ac.jp/crid/1360004231512590208","@type":"Article","resourceType":"学術雑誌論文(journal article)","relationType":["isReferencedBy"],"jpcoar:relatedTitle":[{"@value":"Characterization of naturally occurring protease inhibitor-resistance mutations in genotype 1b hepatitis C virus patients"}]},{"@id":"https://cir.nii.ac.jp/crid/1360283693431169920","@type":"Article","resourceType":"学術雑誌論文(journal article)","relationType":["isReferencedBy"],"jpcoar:relatedTitle":[{"@value":"Ultradeep Sequencing Study of Chronic Hepatitis C Virus Genotype 1 Infection in Patients Treated with Daclatasvir, Peginterferon, and Ribavirin"}]},{"@id":"https://cir.nii.ac.jp/crid/1360285705103360896","@type":"Article","resourceType":"学術雑誌論文(journal article)","relationType":["isReferencedBy"],"jpcoar:relatedTitle":[{"@value":"Rapid emergence of telaprevir resistant hepatitis C virus strain from wildtype clone in vivo"}]},{"@id":"https://cir.nii.ac.jp/crid/1360285705164062464","@type":"Article","resourceType":"学術雑誌論文(journal article)","relationType":["isReferencedBy"],"jpcoar:relatedTitle":[{"@value":"Model incorporating the <i>ITPA</i> genotype identifies patients at high risk of anemia and treatment failure with pegylated‐interferon plus ribavirin therapy for chronic hepatitis C"}]},{"@id":"https://cir.nii.ac.jp/crid/1360285710501788544","@type":"Article","resourceType":"学術雑誌論文(journal article)","relationType":["isReferencedBy"],"jpcoar:relatedTitle":[{"@value":"Prevalence and characteristics of naturally occurring sofosbuvir resistance‐associated variants in patients with hepatitis C virus genotype 1b infection"}]},{"@id":"https://cir.nii.ac.jp/crid/1360285710771208960","@type":"Article","resourceType":"学術雑誌論文(journal article)","relationType":["isReferencedBy"],"jpcoar:relatedTitle":[{"@value":"Emergence of resistant variants detected by ultra‐deep sequencing after asunaprevir and daclatasvir combination therapy in patients infected with hepatitis <scp>C</scp> virus genotype 1"}]},{"@id":"https://cir.nii.ac.jp/crid/1360565165435356544","@type":"Article","resourceType":"学術雑誌論文(journal article)","relationType":["isReferencedBy"],"jpcoar:relatedTitle":[{"@value":"New antiviral therapies for chronic hepatitis C"}]},{"@id":"https://cir.nii.ac.jp/crid/1360567185917774208","@type":"Article","resourceType":"学術雑誌論文(journal article)","relationType":["isReferencedBy"],"jpcoar:relatedTitle":[{"@value":"Inhibitory Effect of a Triterpenoid Compound, with or without Alpha Interferon, on Hepatitis C Virus Infection"}]},{"@id":"https://cir.nii.ac.jp/crid/1360846643093107712","@type":"Article","resourceType":"学術雑誌論文(journal article)","relationType":["isReferencedBy"],"jpcoar:relatedTitle":[{"@value":"Naturally occurring, resistance‐associated hepatitis C virus NS5A variants are linked to interleukin‐28B genotype and are sensitive to interferon‐based therapy"}]},{"@id":"https://cir.nii.ac.jp/crid/1360848656190311040","@type":"Article","resourceType":"学術雑誌論文(journal article)","relationType":["isReferencedBy"],"jpcoar:relatedTitle":[{"@value":"Treatment of chronic hepatitis C virus infection in Japan: update on therapy and guidelines"}]}],"dataSourceIdentifier":[{"@type":"CROSSREF","@value":"10.1002/hep.22549"},{"@type":"CROSSREF","@value":"10.1007/s12072-011-9306-7_references_DOI_40lV79u3ylSDeK737h4tTp7Iv9Y"},{"@type":"CROSSREF","@value":"10.1128/aac.02068-13_references_DOI_40lV79u3ylSDeK737h4tTp7Iv9Y"},{"@type":"CROSSREF","@value":"10.1002/hep.24460_references_DOI_40lV79u3ylSDeK737h4tTp7Iv9Y"},{"@type":"CROSSREF","@value":"10.1111/hepr.12685_references_DOI_40lV79u3ylSDeK737h4tTp7Iv9Y"},{"@type":"CROSSREF","@value":"10.1111/jvh.12271_references_DOI_40lV79u3ylSDeK737h4tTp7Iv9Y"},{"@type":"CROSSREF","@value":"10.1007/s12072-010-9193-3_references_DOI_40lV79u3ylSDeK737h4tTp7Iv9Y"},{"@type":"CROSSREF","@value":"10.1111/j.1365-2893.2012.01640.x_references_DOI_40lV79u3ylSDeK737h4tTp7Iv9Y"},{"@type":"CROSSREF","@value":"10.1128/aac.01780-10_references_DOI_40lV79u3ylSDeK737h4tTp7Iv9Y"},{"@type":"CROSSREF","@value":"10.1111/hepr.12474_references_DOI_40lV79u3ylSDeK737h4tTp7Iv9Y"},{"@type":"CROSSREF","@value":"10.1371/journal.pone.0024907_references_DOI_40lV79u3ylSDeK737h4tTp7Iv9Y"},{"@type":"CROSSREF","@value":"10.1007/s00535-012-0714-9_references_DOI_40lV79u3ylSDeK737h4tTp7Iv9Y"}]}